Pediatrics
Children deserve research built with care, and sponsors deserve data they can rely on. We deliver both through thoughtful study design, global coordination, and patient-centered execution.
Our Approach
Pediatric studies aren’t only about young participants — they involve parents, caregivers, siblings, and clinicians who support the child throughout the journey. At unIQ Trials, we design pediatric research that prioritizes family comfort, clarity, and emotional wellbeing while giving sponsors the operational precision they need.
Family-Centered Study Design
“Every pediatric study involves the whole family. We design studies in a way that minimize stress, reduce disruption, and prioritize comfort at every stage.”
Digital Consent Made Easy
“Interactive eConsent and child-friendly study explanations help families understand the journey with confidence and clarity.”
Designed for Real Life
“Flexible scheduling, tele-visits, and hybrid participation options reduce travel burden and keep children comfortable.”
Emotional Safety & Engagement
“We create a welcoming experience that respects children’s emotions. Age-appropriate tools, calm environments, and friendly clinicians make a difference.”
Stronger Retention, Better Data
“A supportive patient and caregiver experience leads to higher retention and more reliable data — outcome drivers that sponsors value.”
Expertise Across Age Ranges
From neonates to adolescents, pediatric trials require more than scale — they demand precision, sensitivity, and deep developmental understanding. At unIQ Trials, we design and manage studies that account for physiological, cognitive, and emotional differences across every stage of childhood.
Our teams apply age-appropriate protocol designs, dosing strategies, and safety monitoring frameworks that evolve with each developmental phase. We ensure that procedures are feasible, minimally invasive, and aligned with both regulatory expectations and real-world family dynamics.
By combining pediatric clinical insight with operational expertise, we help sponsors generate reliable, high-quality data while creating a study experience that is safe, respectful, and sustainable for young participants and their families.
Pediatric Expertise That Delivers Confidence
At unIQ Trials, we operate as an integrated partner within your study team — bringing structure, transparency, and hands-on ownership to every stage of pediatric trial delivery. Our experience spans pediatric protocol design, operational execution, and regulatory compliance, ensuring studies are conducted with precision, care, and consistency.
We proactively manage the complexities unique to pediatric research by aligning every operational decision with the needs of both the child and their family, while maintaining scientific rigor and inspection-ready standards.
Our pediatric operational strengths include:
Tailored Trial Design
Every visit, procedure, and assessment is built around pediatric feasibility — balancing safety, data integrity, and participant comfort to reduce burden and improve retention.
Age-Appropriate Formulation Expertise
We support studies involving child-friendly dosage forms including liquids, orodispersible tablets, and chewables — ensuring dosing accuracy, adherence, and real-world usability.
Low-Burden Sampling Strategies
Our teams implement minimal-risk blood collection protocols using small-volume techniques and pediatric-appropriate sampling methods to reduce stress and improve the overall trial experience.
Partner with unIQ Trials for compassionate pediatric research.
Enabling Smoother, Smarter Rare-Disease Execution
Patient-Centered Experience
- Simplified consent and easy-to-understand materials
- Multi-language support for global accessibility
- Tele-visits, eConsent & remote symptom tracking
Smarter Enrollment & Site Strategy
- Predictive enrollment based on tumor type & country performance
- Oncology-experienced global sites
- Streamlined pre-screening to reduce screen fails
Stronger Safety & Data Oversight
- Real-time monitoring of AEs/SAEs, labs, imaging
- Machine-assisted detection of risks and deviations
- Faster medical review for cleaner interim analyses